Measurement, causes and management of overweight and obesity in children

Sunita Dhir1, Fiona Ryan

  • 1Department of Paediatric Endocrinology, Children's Hospital, Oxford.

Insights

Childhood obesity is a complex health issue with genetic and environmental causes. Effective management requires population-wide education and lifestyle changes, not just medical interventions.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Childhood obesity represents a significant and escalating global health concern.
  • Its etiology is multifactorial, involving intricate interactions between genetic predispositions and environmental influences.
  • The long-term health implications for affected children and future generations are profound.

Purpose of the Study:

  • To outline the multifactorial nature of childhood obesity.
  • To emphasize the necessity of comprehensive management strategies.
  • To highlight the limited role of pharmaceutical and surgical interventions.

Main Methods:

  • This study is a review of current understanding regarding childhood obesity.
  • It synthesizes information on causative factors and management approaches.
  • Focus is placed on population-level interventions and behavioral strategies.

Main Results:

  • Childhood obesity results from a combination of genetic and environmental factors.
  • Population-wide strategies focusing on education, lifestyle, and behavior modification are crucial.
  • Medical and surgical treatments are reserved for rare, exceptional cases.

Conclusions:

  • Addressing the childhood obesity epidemic necessitates empowering individuals and families toward sustainable lifestyle changes.
  • A holistic, community-based approach is paramount for impactful intervention.
  • Long-term success depends on widespread adoption of healthier behaviors.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...